Alvimopan: ADL 8-2698, ADL 82698, Entrareg, LY 246736.
D000818:Animals; D017326:Clinical Trials, Phase III as Topic; D004066:Digestive System Diseases / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004353:Drug Evaluation, Preclinical; D006801:Humans; D015337:Multicenter Studies as Topic; D010880:Piperidines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic
D010880:Piperidines; D010919:Placebos; C419502:alvimopan